Metabolic syndrome is considered a cluster of cardiovascular risk factors
that are presented both in a single individual. They include insulin resistance, type 2
diabetes mellitus, dyslipidemia, hypertension and central obesity. Metabolic syndrome
is related to systemic alterations that involve several tissues, such as liver, muscle,
adipose tissue, stomach and immune system, varying the production of many
biomolecules. Due to the main outcome of this clinical state being cardiovascular
disease, metabolic syndrome has become a significant clinical priority.This global
disturbance can be first detected and monitored later by several plasmatic biomarkers.
This chapter intends to review a battery of avant-garde biomarkers related to metabolic
syndrome.
Keywords: Adipokines, Adiponectin, Angiotensinogen, Biomarkers, C-reactive
Protein, Cytokines, Insulin Resistance, Interleukin 1, Interleukin 18, Interleukin 6,
Leptin, Metabolic Syndrome, Obesity, Oxidized Low Density Lipoprotein, Plasminogen
Activator Inhibitor 1, Resistin, Tumour Necrosis Factor alpha, Type 2
Diabetes Mellitus, Uric Acid.
